Literature DB >> 16580258

TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis.

Terence M Doherty1, Edward A Fisher, Moshe Arditi.   

Abstract

The Framingham Heart Study established a link between serum lipoproteins and atherosclerosis but a crucially important feature of the disease has been neglected: it is primarily an immunological disorder. Here, we reframe atherosclerosis in terms of recent progress in understanding the immunological mechanisms underlying the disorder, and advance a new conceptual model for the future. We place vascular dendritic cells squarely at the forefront, and propose that a sentinel network of vascular dendritic cells (DCs) sample and process exogenous and endogenous antigens that can trigger an inflammatory nidus within the arterial wall. Our model postulates that two components are essential to the development of atheromata: vascular DCs and intact myeloid differentiation (MyD)88-dependent signaling by Toll-like receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580258     DOI: 10.1016/j.it.2006.03.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  17 in total

1.  A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice.

Authors:  Rosalinda Sorrentino; Atilla Yilmaz; Katja Schubert; Timothy R Crother; Aldo Pinto; Kenichi Shimada; Moshe Arditi; Shuang Chen
Journal:  Cell Immunol       Date:  2015-01-30       Impact factor: 4.868

2.  Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.

Authors:  Shuang Chen; Kenichi Shimada; Timothy R Crother; Ebru Erbay; Prediman K Shah; Moshe Arditi
Journal:  J Am Coll Cardiol       Date:  2018-04-10       Impact factor: 24.094

Review 3.  Natural killer T cells and atherosclerosis: form and function meet pathogenesis.

Authors:  Nicole A Braun; Roman Covarrubias; Amy S Major
Journal:  J Innate Immun       Date:  2010-03-17       Impact factor: 7.349

Review 4.  Current advances in understanding of immunopathology of atherosclerosis.

Authors:  Colin-John Perrins; Yuri V Bobryshev
Journal:  Virchows Arch       Date:  2010-11-11       Impact factor: 4.064

Review 5.  The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2011-04-29       Impact factor: 17.367

6.  Vessel-specific Toll-like receptor profiles in human medium and large arteries.

Authors:  Olga Pryshchep; Wei Ma-Krupa; Brian R Younge; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

7.  Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases.

Authors:  Fanny Angelot; Estelle Seillès; Sabeha Biichlé; Yael Berda; Béatrice Gaugler; Joel Plumas; Laurence Chaperot; Françoise Dignat-George; Pierre Tiberghien; Philippe Saas; Francine Garnache-Ottou
Journal:  Haematologica       Date:  2009-07-31       Impact factor: 9.941

Review 8.  Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques.

Authors:  Emily A Van Vré; Ilse Van Brussel; Johan M Bosmans; Christiaan J Vrints; Hidde Bult
Journal:  Mediators Inflamm       Date:  2011-10-02       Impact factor: 4.711

Review 9.  Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.

Authors:  Fabian Benencia; Leslee Sprague; John McGinty; Michelle Pate; Maria Muccioli
Journal:  J Biomed Biotechnol       Date:  2012-03-15

10.  TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.

Authors:  Yoshikazu Naiki; Rosalinda Sorrentino; Michelle H Wong; Kathrin S Michelsen; Kenichi Shimada; Shuang Chen; Atilla Yilmaz; Anatoly Slepenkin; Nicolas W J Schröder; Timothy R Crother; Yonca Bulut; Terence M Doherty; Michelle Bradley; Zory Shaposhnik; Ellena M Peterson; Peter Tontonoz; Prediman K Shah; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.